calendar
5,248 catalysts · 3,350 8k filing · 771 grant · 577 earnings · 199 approval · 172 phase 2 completion · 133 drug shortage
5,248 catalysts · 3,350 8k filing · 771 grant · 577 earnings · 199 approval · 172 phase 2 completion · 133 drug shortage
Items: 8.01, 9.01
Items: 1.01, 5.02, 7.01, 9.01
Items: 5.02, 7.01, 9.01
Items: 8.01, 9.01
Items: 8.01, 9.01
Items: 1.02, 2.02, 5.02, 9.01
Items: 7.01, 9.01
Items: 2.02, 7.01, 8.01, 9.01
Items: 7.01, 9.01
Items: 7.01
Items: 7.01, 8.01, 9.01
Items: 7.01, 9.01
Items: 7.01, 8.01, 9.01
Items: 8.01
Items: 1.01, 8.01, 9.01
Items: 8.01
Items: 7.01, 8.01, 9.01
Items: 1.01, 2.01, 2.03, 7.01, 9.01
Items: 7.01, 8.01, 9.01
Items: 7.01, 9.01
Items: 7.01, 8.01
Items: 3.01, 3.03, 5.03, 7.01, 9.01
Items: 7.01, 8.01, 9.01
Items: 1.01, 8.01
Items: 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01
Items: 8.01
Items: 5.02
Items: 5.02, 9.01
Items: 5.02, 5.03, 5.07, 9.01
Items: 2.01, 8.01, 9.01
Items: 1.01, 3.02, 8.01, 9.01
Items: 1.01, 3.03, 8.01, 9.01
Items: 2.02
Items: 5.07
Items: 7.01, 9.01
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Gastrointestinal, Oncology. Indication: Bile Duct Cancer (Cholangiocarcinoma), Hepatocellular Carcinoma, Liver Cancer, Liver Cirrhosis, Metastatic Liver Cancer
Therapy area: Central Nervous System. Indication: Unspecified Pain
Therapy area: Cardiovascular. Indication: Hypertension
Therapy area: Infectious Disease. Indication: Hepatitis B
Therapy area: Undisclosed. Indication: Unspecified